HAEMATOLOGIC TECHNOLOGIES, INC.

Basic Information

HAEMATOLOGIC TECHNOLOGIES, INC.
57 RIVER RD
ESSEX JUNCTION, VT, 05452

Company Profile

n/a

Additional Details

Field Value
DUNS: 192057123
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. A Global Test of Hemostatic Risk

    Amount: $351,562.00

    DESCRIPTION (provided by applicant): Phase I funding for this project supported successful studies that were aimed at demonstrating the feasibility of developing an easy to use, global test in the are ...

    STTR Phase II 2007 Department of Health and Human Services
  2. Murine Reagents and Analytical Tools

    Amount: $681,228.00

    DESCRIPTION (provided by applicant): The mechanisms that govern blood coagulation and fibrinolysis have been studied extensively by employing a variety of experimental techniques and in-vivo model sys ...

    SBIR Phase II 2005 Department of Health and Human Services
  3. Fluorogenic Assays for Factor Vlla and Tissue Factor

    Amount: $328,891.00

    DESCRIPTION (provided by applicant): Factor VIIa and tissue factor (TF) are essential proteins for the initiation of blood coagulation. Blood coagulation is initiated when cryptic TF becomes exposed o ...

    SBIR Phase II 2005 Department of Health and Human Services
  4. A Global Test of Hemostatic Risk

    Amount: $99,039.00

    DESCRIPTION (provided by applicant): Although the vast majority of patients who suffer from venous or arterial thrombosis have haemostatic systems that fall within the "normal" range of routine screen ...

    STTR Phase I 2004 Department of Health and Human Services
  5. Murine Reagents and Analytical Tools

    Amount: $75,000.00

    DESCRIPTION (provided by applicant): The mechanisms that govern blood coagulation and fibrinolysis have been studied extensively by employing a variety of experimental techniques and in-vivo model sys ...

    SBIR Phase I 2003 Department of Health and Human Services
  6. Fluorogenic Assays for Factor Vlla and Tissue Factor

    Amount: $74,217.00

    DESCRIPTION (provided by applicant): Factor Vlla and Tissue Factor (TF) are essential proteins for the initiation of blood coagulation. Blood coagulation is initiated when cryptic TF becomes exposed o ...

    SBIR Phase I 2003 Department of Health and Human Services
  7. Assay for In Vivo Activated Protein C (APC) Activity

    Amount: $58,396.00

    In the area of clinical coagulation research, much attention is focused on the molecular eventswhich occur before, during, and after anticoagulant and antithrombotic therapies. For purposes ofmonitori ...

    SBIR Phase I 1994 Department of Health and Human Services
  8. Specific Inhibitors of Activated Protein C

    Amount: $74,065.00

    Factors V and VIII are procofactors which are essential components of the blood coagulationprocess. Deficiency in either of these proteins is associated with severe bleeding disorders, hemophiliaand p ...

    SBIR Phase I 1994 Department of Health and Human Services
  9. SELECTIVE CAPTURE AND QUANTITATION OF SERINE PROTEASES

    Amount: $500,000.00

    THROMBOSIS AND THROMBOLYSIS ARE MAINTAINED IN A DELICATE BALANCE BY A SERIES OF ENZYMATIC REACTIONS. THE COMPONENT ENZYMES ARE PRODUCED AS NEEDED FROM ZYMOGENS, INACTIVE FORMS THAT CIRCULATE IN THE BL ...

    SBIR Phase II 1990 Department of Health and Human Services
  10. IMMUNOASSAY FOR OSTEOCALCIN FRAGMENTS

    Amount: $46,139.00

    CURRENTLY, AN ASSAY TO MEASURE THE RATE OF BONE RESORPTION IN AN EASY AND REPRODUCIBLE MANNER DOES NOT EXIST. OSTEOCALCIN, A BONE-SPECIFIC PROTEIN, IS ASSAYED AS A MARKER OF BONE FORMATION. SINCE THER ...

    SBIR Phase I 1989 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government